Real-world outcomes of patients (pts) with malignant solid tumors treated with immune checkpoint inhibitors (ICI) in relation to smoking status: The SAKK 80/19 SMOKER study

被引：0

作者：

El Saadany, Tamer

Petrausch, Ulf

Mora, Alfonso Rojas

Winder, Thomas

Renner, Christoph

Benda, Magdalena

Reimann, Patrick

Froesch, Patrizia

Jakob, Andreas

Daza, Adriana Clavijo

Mueller, Gisela

Von Moos, Roger Anton Fredy

Mark, Michael Thomas

机构：

[1] Kantonsspital Graubuenden, Div Hematol Oncol, Chur, Switzerland

[2] Hirslanden Zurich, Div Hematol Oncol, Zurich, Switzerland

[3] Swiss Grp Clin Canc Res SAKK, Competence Ctr, Bern, Switzerland

[4] Landeskrankenhaus Feldkirch, Internal Med 2, Feldkirch, Austria

[5] Swiss Tumor Inst, Zurich, Switzerland

[6] Hosp Feldkirch, Div Hematol Oncol, Feldkirch, Austria

[7] Hosp Feldkirch, Div Hematol Oncol, Dept Internal Med 2, Feldkirch, Austria

[8] Ente Osped Cantonale EOC, Oncol Inst Southern Switzerland IOSI, Bellinzona, Switzerland

[9] Tumor Zentrum Aarau, Aarau, Switzerland

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

6619

引用

页数：1